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Biofilms are adherent communities of bacteria contained within a complex matrix.
Although host immune responses to planktonic staphylococcal species have been
relatively well-characterized, less is known regarding immunity to staphylococcal biofilms
and how they modulate anti-bacterial effector mechanisms when organized in this
protective milieu. Previously, staphylococcal biofilms were thought to escape immune
recognition on the basis of their chronic and indolent nature. Instead, we have
proposed that staphylococcal biofilms skew the host immune response away from a
proinflammatory bactericidal phenotype toward an anti-inflammatory, pro-fibrotic response
that favors bacterial persistence. This possibility is supported by recent studies from
our laboratory using a mouse model of catheter-associated biofilm infection, where
S. aureus biofilms led to the accumulation of alternatively activated M2 macrophages that
exhibit anti-inflammatory and pro-fibrotic properties. In addition, relatively few neutrophils
were recruited into S. aureus biofilms, representing another mechanism that deviates
from planktonic infections. However, it is important to recognize the diversity of biofilm
infections, in that studies by others have demonstrated the induction of distinct immune
responses during staphylococcal biofilm growth in other models, suggesting influences
from the local tissue microenvironment. This review will discuss the immune defenses
that staphylococcal biofilms evade as well as conceptual issues that remain to be resolved.
An improved understanding of why the host immune response is unable to clear biofilm
infections could lead to targeted therapies to reverse these defects and expedite biofilm
clearance.
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activation, fibrosis
INTRODUCTION
Biofilms are adherent communities of bacteria contained within a
complex matrix. From a clinical standpoint, biofilm infections of
native tissues or medical devices represent a serious therapeutic
challenge, since organisms are typically recalcitrant to conven-
tional antibiotics (Stewart and Costerton, 2001; Donlan and
Costerton, 2002). Medical device-related infections are typified
by highmorbidity, with their clinicalmanagement often requiring
device removal (Garvin and Hanssen, 1995; Morscher et al., 1995;
Replacement et al., 1995; Lew and Waldvogel, 1997). In addition,
despite prolonged therapy, the failure rate associated with infected
devices is high, primarily due to their failure to be cleared by con-
ventional antibiotics (Schoifet and Morrey, 1990; Wilson et al.,
1990; Burger et al., 1991; Hartman et al., 1991; Rasul et al., 1991;
Tsukayama et al., 1991; Brandt et al., 1997). To date, staphylo-
coccal species remain one of the major causes of both health care-
associated (HA) as well as community-associated (CA) infections.
Staphylococcus epidermidis (S. epidermidis) is a frequent etiolog-
ical agent of biofilm infections on medical devices, including
indwelling catheters and prostheses (Fitzpatrick et al., 2005a;
Otto, 2008; Fey, 2010), whereas Staphylococcus aureus (S. aureus)
is commonly associated with tissue infections, such as endocardi-
tis (Fitzsimmons et al., 2010) and osteomyelitis (Zuluaga et al.,
2006). With the emergence of drug-resistant strains in the 1960s,
primarily methicillin-resistant S. aureus (MRSA), this ubiqui-
tous pathogen is becoming an even greater therapeutic challenge.
Consequently, based on their chronicity, debilitating nature, and
economic impact, biofilm infections are of paramount signif-
icance in modern medicine. Therefore, it is imperative that
we understand the mechanisms whereby staphylococcal biofilms
alter immune recognition pathways to devise novel therapies for
treating these devastating infections.
STAPHYLOCOCCAL BIOFILMS AND TOLL-LIKE
RECEPTORS (TLRs)
Cells of the innate immune system recognize highly con-
served pathogen-associated molecular patterns (PAMPs) that are
expressed by large groups of microorganisms (Kawai and Akira,
2011). These conserved bacterial motifs are identified by a series
of germ-line encoded receptors of the innate immune system
termed pattern recognition receptors (PRRs). Toll-like receptors
(TLRs) represent one PRR class expressed by cells of the innate
immune system that mediate cellular activation in response to
PAMPs (Kaisho and Akira, 2004; O’Neill, 2004). Thirteen TLRs
have been described in the human and 10 in the mouse, each
conferring responsiveness to various infectious agents as well as
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some endogenous ligands (Kopp andMedzhitov, 2003; Kawai and
Akira, 2011). Staphylococcal species harbor a complex cell wall
containing PAMPs that represent TLR2 ligands, namely lipotei-
choic acid (LTA) and peptidoglycan (PGN) (Morath et al, 2002;
Dziarski, 2003;Weber et al., 2003). PGN is released during normal
bacterial growth as well as from dying organisms within staphy-
lococcal biofilms (Mercier et al., 2002; Cerca et al., 2006; Moscoso
et al., 2006; Qin et al., 2007; Strunk et al., 2010). Likewise,
polysaccharide intercellular adhesin (PIA) and phenol-soluble
modulin (PSM) expression in S. epidermidis promotes biofilm
formation and can be recognized by TLR2 (Hajjar et al., 2001;
Stevens et al., 2009). Staphylococcal lipoproteins (Lpp), a large
family of membrane-anchored proteins, have also been identi-
fied as potent TLR2 ligands (Hashimoto et al., 2006a,b; Kurokawa
et al., 2009). Some reports indicate that Lpp contaminating LTA
and PGN preparations is responsible for most of the observed
TLR2 stimulatory action (Travassos et al., 2004; Hashimoto et al.,
2006a,b; Kurokawa et al., 2009). However, a synthetic LTA analog
devoid of lipoproteins has also been shown to possess immune
activity (Morath et al, 2002; Deininger et al., 2003). Regarding
the role of PGN as a TLR2 agonist, a subsequent report demon-
strated that the solubility characteristics of purified PGN dictated
whether it was capable of triggering TLR2 (Dziarski and Gupta,
2005). Importantly, the ability of PGN to activate TLR2 can be
destroyed by certain purification methods, leading to discrepan-
cies in potency for TLR2 activation. Therefore, the immunostim-
ulatory role of LTA and the innate immune receptor specificity of
staphylococcal PGN for TLR2 remains an issue of debate. TLR9
is an intracellular receptor that recognizes unmethylated CpG
motifs characteristic of bacterial DNA (Hemmi et al., 2000; Bauer
et al., 2001). MammalianDNA is methylated on guanine residues,
which serves as a critical self vs. non-self discriminator. Upon
phagocytosis and digestion of bacteria in the phagosome, bac-
terial DNA is liberated and engages TLR9. However, it is well
recognized that extracellular DNA (eDNA) can also trigger TLR9-
dependent activation, which is relevant to biofilms due to the
extensive amount of eDNA within the matrix (Whitchurch et al.,
2002; Allesen-Holm et al., 2006; Rice et al., 2007). Innate immune
cells, including macrophages, neutrophils (PMNs), and dendritic
cells, express TLR2 and TLR9 and are competent to respond to
both Lpp/PGN/LTA and eDNA, respectively, which culminates
in the induction of a wide array of classical pro-inflammatory
mediators and bactericidal activity (Takeuchi et al., 1999; Bauer
et al., 2001; Hertz et al., 2001; Jones et al., 2001; Kirschning and
Schumann, 2002; Hayashi et al., 2003).
The role for TLRs in mediating innate immune recognition
of staphylococcal species during planktonic growth has been
well-characterized (Yoshimura et al., 1999; Takeuchi et al., 2000;
Mullaly and Kubes, 2006; Stevens et al., 2009; Strunk et al.,
2010). However, recent reports have determined that one mech-
anism utilized by biofilms to evade host immunity is by cir-
cumventing TLR2 and TLR9 recognition (Figure 1) (Bernthal
et al., 2011; Thurlow et al., 2011). This agrees with the find-
ing that patients bearing mutations which inactivate TLR2 have
no increased risk of developing post-arthoplasty S. aureus infec-
tions (El-Helou et al., 2011). In contrast, the ability of S. aureus
biofilms to evade TLR9 recognition differs from P. aeruginosa
biofilms, since eDNA has been demonstrated to be a major
proinflammatory stimulus during P. aeruginosa biofilm growth
(Fuxman Bass et al., 2010). This emphasizes the importance of
bacterial species and growth state in dictating whether innate
immune sensor mechanisms will be effective at clearing infec-
tion. It is also possible that S. aureus biofilms may be recog-
nized by alternative PRRs besides TLR2 or TLR9. For example,
eDNA could also be sensed by other intracellular PRRs such
as AIM2 or DNA-dependent activator of IFN-regulatory fac-
tors (DAI) (Vilaysane and Muruve, 2009; Hornung and Latz,
2010). In addition, the degradation product of staphylococcal
PGN, muramyl dipeptide, can be sensed by the cytoplasmic PRR
nucleotide-binding oligomerization domain-containing protein
2 (NOD2) to elicit proinflammatory mediator release (Girardin
et al., 2003; Volz et al., 2010). The mechanism(s) responsible
for TLR2/TLR9 evasion by S. aureus biofilms are not known
but could also be explained by ligand inaccessibility. Biofilms are
encased within a complex three-dimensional structure with few
free bacteria exposed at the outer surface, thus avoiding detec-
tion by PRRs expressed on the surface of phagocytes (Thurlow
et al., 2011). Likewise, complex polysaccharide polymers that
are known components of the biofilm matrix (Flemming and
Wingender, 2010), may interfere with optimal engagement of
potential ligands with TLRs. Understanding the receptor reper-
toire triggered by staphylococcal biofilms may enable the selective
targeting of these molecules to facilitate pathogen elimination
and/or render the biofilm more sensitive to conventional antibi-
otic therapies.
ROLE FOR INTERLEUKIN-1β (IL-1β) AND OTHER
MyD88-DEPENDENT PATHWAYS IN IMMUNE
RECOGNITION OF STAPHYLOCOCCAL BIOFILMS
In contrast to a lack of TLR2 and TLR9 involvement during
staphylococcal biofilm infections, a recent report has revealed a
role for IL-1β in controlling early bacterial burdens in a post-
arthroplasty S. aureus biofilm infection model (Bernthal et al.,
2011). Specifically, biofilm formation was enhanced in IL-1β
KO mice concomitant with decreased PMN recruitment; how-
ever, PMN infiltrates were visualized by H&E staining in this
study and quantitative assessment by flow cytometry was not
performed. It is worth noting that PMN influx is minimal
in a model of s.c. catheter-associated S. aureus biofilm infec-
tion (Figure 2), which may represent differences in the biofilm
locale or degree of planktonic infection surrounding the biofilm.
Studies from our laboratory have recently investigated the role of
myeloid differentiation factor 88 (MyD88), the common down-
stream adaptor utilized by both the IL-1 receptor (IL-1R) and
TLRs (Hanke and Kielian, in revision), in regulating S. aureus
biofilm growth. MyD88 signaling culminates in NF-κB-mediated
transcription and until our work, nothing was known regard-
ing the role of MyD88- or NF-κB-dependent signaling during
staphylococcal biofilm infections. Utilizing a well-characterized
model of catheter-associated S. aureus biofilm infection (Rupp
et al., 1999; Cassat et al., 2007; Thurlow et al., 2011), MyD88
KO mice displayed significant increases in bacterial burdens on
catheters as well as surrounding tissues throughout the course of
infection compared to WT animals. Additionally, S. aureus titers
Frontiers in Cellular and Infection Microbiology www.frontiersin.org May 2012 | Volume 2 | Article 62 | 2
Hanke and Kielian Biofilm evasion of immune responses
FIGURE 1 | The signaling adaptor MyD88 is pivotal for regulating
biofilm development. Recent studies have revealed important roles for
IL-1β and MyD88-dependent pathways in controlling bacterial burdens
during S. aureus biofilm growth, whereas biofilms evade TLR2/TLR9
recognition. The macrophage is a major cellular infiltrate during
device-associated biofilm infections; however, current evidence
indicates that macrophage microbicidal properties are inhibited by
the biofilm.
FIGURE 2 | Neutrophil recruitment into S. aureus biofilms in vivo is
limited. C57BL/6 mice were infected with 5 × 105 CFU USA300 LAC either
in the lumen of surgically implanted catheters or s.c. in the absence of any
indwelling device to establish biofilm and abscess infections, respectively.
Animals were sacrificed at days 3 or 7 following S. aureus exposure,
whereupon tissues surrounding infected catheters or s.c. injection sites
were collected and subjected to immunofluorescence staining for the
neutrophil-specific marker Ly-6G (red) and visualized by confocal
microscopy (original magnification ×20).
were significantly elevated in the heart and kidney of MyD88 KO
mice, demonstrating a role for MyD88 in bacterial containment
at the site of biofilm infection. Furthermore, immunofluores-
cence staining revealed an increased fibrotic response associated
with biofilms in MyD88 KO animals, which coincided with
increased recruitment of alternatively activated M2 macrophages
(Hanke and Kielian, in revision). Collectively, these studies reveal
a role for IL-1β, potentially mediated through MyD88 signaling,
in S. aureus biofilm containment (Figure 1). Although it is evi-
dent that these pathways influence biofilm development, they
are not sufficient to eradicate staphylococcal biofilms, since these
infections persist in an immunocompetent host. Instead, tonic
MyD88/IL-1β action could account for the finding that biofilm
burdens remain relatively constant throughout the course of
infection (Thurlow et al., 2011), which likely represents an equi-
librium between bacterial dispersal from the biofilm, clearance of
planktonic organisms (presumably via MyD88/IL-1β pathways),
and continued biofilm growth.
Although it is clear that IL-1β and MyD88-dependent path-
ways can influence S. aureus biofilm development, the precise
molecular pathways remain to be defined. In particular, numer-
ous receptors utilize MyD88, including multiple TLRs, IL-1R,
IL-18R, and IL-33R and it is uncertain which is most relevant
or alternatively, if multiple pathways are triggered and act in
an additive/synergistic manner. Based on the findings with IL-
1β-deficient mice (Bernthal et al., 2011), it is likely that IL-1RI
signaling plays a key role, but this remains to be determined.
Importantly, IL-1β is produced as an inactive precursor that
requires proteolytic cleavage for its release. This process requires
the coordinate induction of a two-signal model mediated by TLRs
(signal 1) and Nod-like receptors (NLR; signal 2), the latter of
which forms the inflammasome that is responsible for process-
ing the inactive forms of IL-1β and IL-18 into their mature states
(Craven et al., 2009; Schroder and Tschopp, 2010). Signal 1 is
elicited by TLR signaling though MyD88 that triggers the tran-
scriptional induction of pro-IL-1β and pro-IL-18, which remain
inactive until a second signal is initiated. Signal 2 has been shown
to originate within the host cell cytoplasm and is mediated by
the sensing of a danger signal by members of the NLR family
of intracellular PRRs. With regard to staphylococcal infections,
signal 2 can be triggered by intact bacteria or purified α- and
γ-hemolysins, which lead to K+ efflux from the cell (Craven
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et al., 2009; Hanamsagar et al., 2011). Currently, we know nothing
about what receptors upstream ofMyD88 are required for staphy-
lococcal biofilm recognition or signals that lead to IL-1β tran-
scription or proteolytic processing. These issues will be important
to evaluate in the quest to unveil promising therapeutic targets for
staphylococcal biofilm eradication.
Signals emanating from TLRs, IL-1R, and numerous cytokine
receptors trigger activation of the transcription factor NF-κB.
The NF-κB family regulates the expression of numerous genes
associated with proliferation, differentiation, and cell death, as
well as innate and adaptive immune responses, which rep-
resents an attractive target for exploitation by staphylococcal
species (Rahman and McFadden, 2011). Indeed, NF-κB sig-
naling is the most frequent intracellular pathway targeted by
numerous microbes to subvert the immune response (Finlay and
McFadden, 2006). S. epidermidis PIA-, accumulation-associated
protein (Aap)-, or extracellular matrix-binding protein (Embp)-
dependent biofilms were protected from macrophage phagocytic
uptake and induced minimal NF-κB activation and IL-1β pro-
duction (Schommer et al., 2011). Interestingly, similar to our
previous results where physical disruption of the biofilm struc-
ture allowed for macrophage phagocytosis, mechanical dispersal
of S. epidermidis biofilms partially restored NF-κB activation
(Schommer et al., 2011; Thurlow et al., 2011). Together, these
results indicate that staphylococcal biofilms possess mechanisms
to circumvent macrophage phagocytic uptake and limit proin-
flammatory activity by attenuating NF-κB activity.
Another study has shown that inflammatory cytokines were
augmented during early S. aureus biofilm infection, whereas anti-
inflammatory infiltrates predominated later. Based on these find-
ings, the authors proposed that the acute inflammatory response
induced tissue damage to facilitate biofilm growth (Prabhakara
et al., 2011). However, the infectious inoculum utilized was
rather high and the implanted device was coated with bacte-
ria prior to surgical implantation, which might account for the
initial proinflammatory response if a significant degree of plank-
tonic organisms were present prior to mature biofilm formation.
Since it takes time for biofilm maturation to occur, the anti-
inflammatory response that was reported at later time points
might be a better indication of the immune response to a mature
biofilm, which is supported by other studies (Prabhakara et al.,
2011; Thurlow et al., 2011). However, differences in the sites of
biofilm infection, methods of inoculating foreign devices (i.e.,
infecting devices prior to insertion or inoculation directly into the
implanted device in vivo), and infectious inoculums may influ-
ence the nature of the host immune response to staphylococcal
biofilms. The relative impact of each of these factors remains to
be determined.
ANTIMICROBIAL PEPTIDES AND STAPHYLOCOCCAL
BIOFILMS
The innate immune response to numerous microbial infec-
tions, including staphylococcal species, is mediated, in part, by
pre-existing soluble factors that recognize and destroy pathogens
or target them for killing by macrophages and PMNs. Two exam-
ples are antimicrobial peptides (AMPs) and the complement
pathway Medzhitov and Janeway, 2000; Medzhitov, 2007, both
of which are induced immediately following infection and rep-
resent a first line of defense against invading microbes. The
complement system consists of blood-derived proteins that are
activated in an enzymatic cascade to eliminate pathogens from
the host. PMN killing of planktonic S. epidermidis is complement-
dependent and biofilm formation has been shown to trigger
complement activation in a PIA-dependent manner (Clark and
Easmon, 1986; Kristian et al., 2008; Fredheim et al., 2011).
However, S. epidermidis biofilms impair IgG and complement
deposition, resulting in increased resistance to opsonization and
phagocyte-mediated killing (Kristian et al., 2008; Fredheim et al.,
2011). AMPs are universal innate defense molecules in humans
and other higher organisms, which despite co-evolution with bac-
teria have retained their efficacy, as bacteria have yet to develop
wide-spread resistance. These peptides show narrow or broad-
spectrum activity against bacteria, fungi, viruses, and/or para-
sites. The net-positive charge, amphipathicity, and small size of
AMPs allow for the disruption of microbial membranes and also
inhibit cell wall, nucleic acid, and protein biosynthesis (Yeaman
and Yount, 2003; Brogden, 2005). Currently, only a few AMPs
have shown efficacy against S. aureus biofilms by either inhibit-
ing biofilm formation or down regulating the expression of genes
involved in biofilm development (Lopez-Leban et al., 2010; Dean
et al., 2011). Recent collaborative studies from our laboratory
have identified a synthetic AMP, DASamP1, that selectively kills
MRSA and prevents biofilm formation in vivo (Menousek et al.,
2012). Although AMPs have not been extensively explored for
their anti-biofilm activity, these initial studies suggest that this
class of antimicrobials deserves attention and could conceivably
exert additive/synergistic effects with other approaches for the
treatment of staphylococcal biofilm infections.
INNATE CELLULAR IMMUNITY
To date, most studies investigating innate immune responses to
biofilms have been performed with P. aeruginosa and S. epider-
midis, where PMNs have been shown to phagocytose biofilm-
associated bacteria and produce oxidative bursts, albeit at reduced
levels compared to planktonic bacteria (Jensen et al., 1990; Jesaitis
et al., 2003; Walker et al., 2005; Chandra et al., 2007; Kristian
et al., 2008; Graves et al., 2010). Neutrophils represent a first
line of cellular defense against bacterial infections and possess a
potent arsenal of bactericidal compounds, including defensins,
cathelicidins, and lysozyme (Nathan, 2006; Nauseef, 2007). In
terms of their bactericidal activity, PMNs are most notable for
their ability to produce large amounts of reactive oxygen inter-
mediates (ROI) catalyzed by NADPH oxidase. In addition to
ROI production, PMNs can also secrete several proinflamma-
tory cytokines, including TNF-α and IL-1β as well as chemokines,
such as CXCL2 (macrophage inflammatory protein-2; MIP-2)
and CXCL1 (KC, keratinocyte-derived chemokine; both are func-
tional mouse homologs of IL-8) and CCL3 (MIP-1β) (Cassatella,
1995; Witko-Sarsat et al., 2000; Nathan, 2006). Although PMNs
exert S. aureus bactericidal activity under planktonic conditions
(Fournier and Philpott, 2005; Graham et al., 2007), the direct role
of these cells in modulating S. aureus biofilm growth has not yet
been examined. Although a previous report had suggested that
PMNs were competent to invade a S. aureus biofilm, this study
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was performed with peripheral blood leukocytes that represented
a mixed cell population of PMNs, monocytes, and T and B lym-
phocytes (Leid et al., 2002). Therefore, the dynamics of PMN
interactions with biofilms could not be definitively determined.
Interestingly, this study also detected mammalian cytokine pro-
duction in biofilm-conditioned supernatants, which may be
explained by interference of S. aureus protein A, a MSCRAMM
that binds the Fc portion of immunoglobulins, non-specifically
binding to capture/detection antibodies in the ELISA assay. More
recent studies using 85–95% pure PMN populations suggested
that both S. aureus and S. epidermidis biofilms are phagocytosed
by PMNs albeit to different extents, with S. aureus being more
susceptible to phagocytic uptake (Günther et al., 2009; Graves
et al., 2010; Meyle et al., 2010). However, it is important to note
that these studies evaluated immature S. aureus biofilms grown
under what might be considered sub-optimal conditions, such as
continuous shaking and on non-coated surfaces (Wagner et al.,
2011). Therefore, the thickness and complexity (i.e., presence
of secondary tower structures) of biofilms should be considered
when assessing the degree of phagocytosis by various immune cell
populations.
As previously mentioned, PMN infiltrates were reduced dur-
ing post-arthroplasty S. aureus biofilm infection in IL-1β deficient
mice; however, the functional importance of PMNs in control-
ling bacterial burdens was not explored in this report (Bernthal
et al., 2011). Future studies with neutrophil-depleted mice will
provide definitive evidence regarding the role of PMNs in biofilm
clearance in models where significant infiltrates are observed.
Likewise, potential bystander damage originating from the cyto-
toxic, proteolytic, and proinflammatory effector functions of
PMNs in tissue degradation and osteolysis should also be exam-
ined. A recent study reported a prominent leukocyte infiltrate
associated with post-traumatic osteomyelitis, which consisted
predominantly of activated PMNs. The authors proposed that
during the ineffective “frustrated” attempt to phagocytose bac-
teria, PMNs release cytotoxic and proteolytic molecules that, in
turn, amplify tissue injury in conjunction with biofilm-derived
toxins and proteolytic enzymes (Wagner et al., 2003, 2005). As
mentioned earlier, PMN recruitment is minimal in a differ-
ent model of S. aureus biofilm infection (Figure 2), and instead
macrophage infiltrates predominate (Thurlow et al., 2011). The
reasons responsible for differential PMN recruitment in various
biofilm models may be influenced by the extent of tissue vas-
cularization, maturity, and extent of biofilm development, and
whether the inoculum used to establish biofilm formation may
lead to an initial planktonic component that results in early PMN
recruitment that is independent of the developing biofilm. The
latter point is particularly relevant, since it is reasonable to assume
that not all organisms will attach to an artificial device when
introducing bacteria adjacent to the implant. In addition, larger
inoculums may result in more planktonic bacteria neighboring
the device, which are known to elicit a robust proinflammatory
response, and conceivably augment PMN infiltrates. In contrast,
in the context of lower inoculums, even if some organisms do
not attach, the small number of planktonic bacteria would not
be expected to elicit a robust inflammatory response. In addition,
it could be argued that low inoculums more accurately mimic the
events that would be encountered during native device seeding
in vivo. Another factor to consider is the type of device studied.
In the case of a hollow catheter, bacteria introduced directly into
the lumen may be afforded additional protection from immune
recognition by shielding provided by the catheter wall. In the case
of a solid device, bacteria are immediately exposed to host tis-
sues, in theory enabling an immediate proinflammatory response.
Regardless, these issues should become clearer as additional
in vivo studies examining staphylococcal biofilm pathogenesis are
performed.
Several studies investigating innate immunity to staphylo-
coccal species have focused on PMNs (Kobayashi et al., 2003;
Anwar et al., 2009; Graves et al., 2010), whereas macrophage
responses have received relatively less attention. Although PMNs
are important antimicrobial effectors, their transcriptional capac-
ity is limited, and their short lifespan requires constant recruit-
ment into infection sites (Yamashiro et al., 2001; Borregaard,
2010; Mantovani et al., 2011). In contrast, resident macrophages
are present in virtually all host tissues and represent a critical
antimicrobial effector population and immediate line of defense
against microbial invasion (Serbina et al., 2008; Gonzalez-Mejia
and Doseff, 2009). Macrophages are more long-lived compared to
PMNs and produce numerous proinflammatory mediators that
are critical for immune cell recruitment and activation (Silva,
2010, 2011). In addition, macrophages possess potent phago-
cytic capacity and, like PMNs, can produce ROI and RNI species.
However, macrophages are a major source of pro-inflammatory
cytokines and chemokines, since activated cells survive signifi-
cantly longer compared to PMNs (Furze and Rankin, 2008).
Examination of several proinflammatory signals responsi-
ble for macrophage and PMN recruitment (CCL2 and CXCL2,
respectively) and activation (TNF-α and IL-1β) were significantly
reduced in S. aureus biofilm infected tissues (Thurlow et al.,
2011). Of note, the disconnect between reduced CCL2 levels
and prominent macrophage infiltrates during biofilm formation
indicate that existence of alternative macrophage chemoattrac-
tant signals, the identity of which remains unknown. Inducible
nitric oxide synthase (iNOS) expression was also decreased,
whereas arginase-1, a key enzyme involved in the collagen biosyn-
thetic pathway was increased in macrophages surrounding the
biofilm. Because both iNOS and arginase-1 compete for argi-
nine to initiate their respective biosynthetic pathways, the pref-
erential induction of arginase-1 expression in biofilm-associated
macrophages likely results in skewing the immune response away
from bacterial killing to favor fibrosis (Thurlow et al., 2011).
Indeed, this possibility appears plausible based on three pieces
of evidence. First, biofilm-associated device infections in ani-
mal models as well as humans are typified by a robust fibrotic
response (Pickering et al., 1989; Buret et al., 1991; Duch and
Yee, 2001), which might inadvertently serve to further sequester
the biofilm from immune recognition. Second, in vitro and
in vivo studies from our laboratory demonstrate that S. aureus
biofilms skew macrophages toward an anti-inflammatory M2
phenotype (Thurlow et al., 2011), which contributes to fibro-
sis. Likewise, S. epidermidis biofilms with higher proportions
of viable, but non-culturable dormant bacteria have recently
been shown to induce less macrophage activation as revealed
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by reduced pro-inflammatory cytokine production in vitro and
expression of surface activation markers in vivo (Cerca et al.,
2011). Third, various ECM molecules have been shown to atten-
uate immune cell proinflammatory activity, in accordance with
a wound healing environment (Adair-Kirk and Senior, 2008;
Korpos et al., 2009; Rodero and Khosrotehrani, 2010; Sorokin,
2010; Mahdavian Delavary et al., 2011; Wight and Potter-Perigo,
2011). Based on these observations, we propose that staphy-
lococcal biofilms skew the host innate immune response from
a classical pro-inflammatory bactericidal phenotype toward an
anti-inflammatory, pro-fibrotic response to favor bacterial persis-
tence (Figure 3). The typical response ofmacrophages to bacterial
infections involves the induction of genes related to proinflam-
matory M1 polarization that is usually associated with protection
during acute infections. However, a growing number of stud-
ies demonstrate that some organisms have evolved sophisticated
strategies to interfere with M1 polarization by either inhibiting
macrophage microbicidal activity (Vazquez-Torres et al., 2000),
hindering M1 cytokine expression/secretion (Bost and Clements,
1997; Dornand et al., 2002), or by producing virulence fac-
tors that directly impede NF-κB activation (Pathak et al., 2007).
In contrast, bacterial persistence is often linked to macrophage
reprogramming toward an anti-inflammatory M2 state (reviewed
in Benoit et al., 2008). Additional studies are warranted to tease
apart this relationship from a mechanistic perspective.
Although we and others have previously demonstrated that
PMNs are capable of phagocytosing S. aureus biofilms (Günther
et al., 2009; Graves et al., 2010; Thurlow et al., 2011), macrophages
are limited in their ability to ingest S. aureus when organized
within a biofilm compared to planktonic bacteria (Thurlow et al.,
2011). Importantly, macrophages were capable of phagocytosing
FIGURE 3 | Macrophage activation pathways. Depending on the local
cytokine milieu, macrophages can be polarized toward a classical M1 or
alternatively activated M2 phenotype, which possess potent antimicrobial
and pro-fibrotic activities, respectively. Based on these attributes, and the
finding that S. aureus biofilms are associated with a prominent M2
macrophage infiltrate, we propose that the ability of biofilms to elicit a M2
dominant response is responsible, in part, for biofilm persistence in an
immunocompetent host.
bacteria from mechanically disrupted biofilms, suggesting either
(1) the failure to physically engulf the complex biofilm struc-
ture that exceeds the size of a macrophage by several orders of
magnitude, or (2) inability opsonize intact biofilms. The lat-
ter is supported by a previous study showing that IgG and
C3b deposition is reduced on the surface of S. epidermidis
biofilms compared with planktonic bacteria (Kristian et al., 2008).
Interestingly, macrophages incubated with conditioned super-
natants from S. aureus biofilms in vitro were unable to phago-
cytize latex beads or planktonic bacteria, which were readily
internalized by untreated macrophages (Figure 4). Consequently,
it appears that biofilms not only alter macrophage activation
states, but also paralyze their phagocytic potential in response
to particulate material that would be readily internalized under
normal conditions. The implications of this phenomenon dur-
ing biofilm infections are envisioned to be significant, in that
macrophages would be impaired in their ability to scavenge dead
cells/debris or contribute to tissue remodeling in the vicinity of
the biofilm. Although these possibilities remain speculative, they
could conceivably contribute to biofilm persistence in vivo.
The majority of macrophages that invaded S. aureus biofilms
in vitro were dead compared to those that remained above the
biofilm surface (Thurlow et al., 2011). There are a number of
potential mechanisms that may account for the differential sensi-
tivity ofmacrophages to cell death based on their physical distance
from the biofilm, which can be framed in the context of metabolic
“layers” that have been proposed for the biofilm (Spormann,
2008; Stewart and Franklin, 2008; Bester et al., 2010). These zones
represent a complex relationship between anaerobic and aerobic
microenvironments within the biofilmmass, bacterial-influenced
fluctuations in pH, and bacterial metabolic profiles that may
affect macrophage survival due to the release of toxic byproducts.
Furthermore, the biofilm proper may contain a high concentra-
tion of lytic toxins, which in combination with the bulky biofilm
matrix may lead to frustrated phagocytosis and cell death (Hoiby
et al., 1995; Costerton et al., 1999). Additional studies are war-
ranted to investigate the factor(s) that are responsible for innate
immune cell death upon contact with staphylococcal biofilms.
FIGURE 4 | Phagocytosis is impaired in response to S. aureus biofilms.
Bone marrow-derived macrophages labeled with CellTracker Blue (blue)
were incubated with (A) fresh medium or (B) biofilm-conditioned
supernatants for 2 h, whereupon planktonic S. aureus expressing GFP
(green) and fluorescent latex beads (red) were added for 1 h to determine
macrophage phagocytic ability by confocal microscopy. Arrows indicate
phagocytic macrophages.
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FIBROSIS
Biofilm infections typically become surrounded by a fibrous cap-
sule that is likely driven by host pro-fibrotic pathways (Pickering
et al., 1989; Buret et al., 1991; Duch and Yee, 2001). However, lit-
tle information is available regarding the host-derived factors that
trigger biofilm encapsulation or its consequences on the evolving
immune response. Although it is presumed that biofilm encapsu-
lation by the host represents a protective response to contain the
infection, this process may inadvertently provide survival advan-
tages to the bacteria. For example, despite an early macrophage
infiltrate, immunofluorescence staining demonstrated that the
majority of cells remained distant from the infection site, with
only a few macrophages recruited to the biofilm surface (Thurlow
et al., 2011). Therefore, the fibrotic capsule may provide a pro-
tective barrier to physically sequester invading immune cells from
the biofilm and/or limit antibiotic penetration into the infection
site (Xu et al., 2000; Singh et al., 2010). Alternatively, fibrosis may
enable the dissemination of S. aureuswhen organisms are released
from the biofilm through their ability to produce proteases and
adhesion molecules that demonstrate affinity for host fibrotic
molecules (Gordon and Lowy, 2008). What remains unknown is
whether encapsulation is triggered by virulence factor(s) released
from the biofilm and the consequences of fibrosis formation.
The host immune response plays a critical role during both
physiological and pathological fibrosis by releasing several pro-
fibrotic cytokines and other molecules that participate in extra-
cellular matrix (ECM) remodeling to induce fibrosis (Mauviel,
2005; Lupher and Gallatin, 2006; Wynn, 2008). Fibrosis has
been linked to the transition of macrophages into an alterna-
tively activated M2 phenotype, which is dictated, in part, by
the pro-fibrotic Th2 cytokines IL-4, IL-5, and IL-13 (Wynn,
2004; Lupher and Gallatin, 2006). Recent studies suggest that
certain pathogens favor the transition of the immune response
from a classical pro-inflammatory to an anti-inflammatory state
(Bouhlel et al., 2007; Gallardo-Soler et al., 2008). Since fibro-
sis typically ensues following the dampening of inflammation
(Lupher and Gallatin, 2006), which coincides with the increased
expression of anti-inflammatory mediators, this provides a link
between the two processes. By extension, it appears plausible that
biofilm growth actively directs the ensuing fibrotic response. Our
recent studies in the mouse catheter-associated biofilm infec-
tion model demonstrated that infected catheters become rapidly
surrounded by a fibrotic capsule composed primarily of type I
collagen and fibronectin (Hanke and Kielian, in revision). The
coating of artificial surfaces and implanted medical devices with
platelets and host ECM proteins, such as fibronectin, facilitate
S. aureus adherence in vitro (Foster, 1996). In terms of coagulase-
negative staphylococci, others have reported enhanced adhesion
with various plasma proteins, including fibronectin (Herrmann
et al., 1988). These interactions are facilitated by the numerous
MSCRAMMs that are expressed by S. aureus, which have known
binding affinity for monomeric collagen and fibronectin (Rivera
et al., 2007). However, others have demonstrated that fibronectin
and its proteolytic fragments inhibited S. epidermidis adhesion to
plastic surfaces (Dunne and Burd, 1993). This might be explained
by either the growth phase when bacteria were harvested (since
MSCRAMMs are maximally expressed during log phase growth
in broth cultures) or the fact that S. epidermidis is more adept at
binding to inert surfaces compared to S. aureus. In this case, coat-
ing with exogenous molecules is more dispensable and conceiv-
ably, could deter S. epidermidis binding due to charge repulsion,
although this remains highly speculative.
As previously mentioned, numerous studies have identi-
fied macrophages as a major effector cell in fibrosis (Lupher
and Gallatin, 2006). It is now clear that macrophages can be
programmed toward distinct activation phenotypes categorized
as classical M1 and alternatively activated M2 macrophages
(Gordon, 2003; Mantovani et al., 2004). Th1 cytokines, such as
IFN-γ, activate iNOS and proinflammatory cytokine expression
in M1 macrophages, leading to their potent antimicrobial activ-
ity. Recently, M2 macrophages have been further subdivided into
three types, based on the cytokine milieu encountered and the
mediators they secrete. M2a represent what the field collectively
considers “M2” macrophages, which are driven by IL-4 and IL-13
and are associated with TGF-β production and arginase-1 (ARG1)
activity, both of which are pro-fibrotic (Munder et al., 1998; Hesse
et al., 2001; Gordon, 2003). M2b macrophages are induced fol-
lowing exposure to PAMPs in combination with IL-1β and are
typified by their production of IL-10 and select chemokines. M2c
macrophages arise from exposure to TGF-β and IL-10; however,
less is known about their secretory profile. It is important to
note that these activation states likely represent a continuum that
is influenced by the local inflammatory milieu and importantly,
macrophages exhibit plasticity in their ability to adapt to chang-
ing microenvironments (Gordon and Taylor, 2005; Martinez
et al., 2009; Biswas and Mantovani, 2010). With regard to anti-
bacterial responses and fibrosis, iNOS and arginase-1 are involved
in opposing pathways (Figure 3). Namely, iNOS is proinflam-
matory and part of a conserved “core host response” to infec-
tion, whereas ARG1 is considered anti-inflammatory and drives
fibrotic reactions (Benoit et al., 2008). Therefore, the transition of
macrophages from an M1 to an M2 phenotype facilitates fibrosis.
Future studies are needed to investigate these macrophage popu-
lations throughout the course of staphylococcal biofilm infection
to elucidate whether a particular type predominates, particularly
with regard to the M2a, M2b, and M2c states. In addition, it will
be interesting to determine whether differences in macrophage
polarization are observed in S. aureus compared to S. epidermidis
biofilms, since the former is significantly more invasive and capa-
ble of causing systemic disease (Gordon and Lowy, 2008). In this
case, one could envision that the fibrotic response may be more
extensively developed with S. aureus in an attempt to prevent
infection dissemination.
ADAPTIVE IMMUNITY AND STAPHYLOCOCCAL BIOFILMS
Although little information is currently available regarding adap-
tive immune responses against staphylococcal biofilms, there is
great interest in developing a vaccine to prevent biofilm infec-
tions. One challenge toward the development of such a vaccine
is identifying appropriate immunodominant antigen(s) that are
capable of eliciting robust antimicrobial activity. In fact, the fail-
ure to find one such an antigen has led many groups to design
multivalent vaccines in hopes of inducing antibody-mediated
protection (Brady et al., 2011). The efficacy of a quadrivalent
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vaccine consisting of cell wall- andmembrane-associated proteins
whose expression is increased during S. aureus biofilm growth
has been recently examined (Brady et al., 2011). Neither the
quadrivalent nor monovalent vaccines were effective at clearing
S. aureus biofilms in vivo, and only in combination with pow-
erful antibiotic treatment was any effect achieved (Brady et al.,
2011). It is reasonable to predict that antibodies may be capable of
clearing planktonic bacteria released from the biofilm; however,
it seems less likely that antibodies will be effective in neutral-
izing bacteria deep within the biofilm, since many organisms
are embedded within the matrix and not accessible to antibody
opsonization. Indeed, even in individuals with excellent cellu-
lar and humoral immune reactions, biofilm infections are rarely
resolved by the host unless the biofilm itself is physically removed.
For this reason, biofilms are typically persistent infections even
after repetitive cycles of antibiotic therapy, which is a testament to
the powerful array of factors that staphylococci possess to thwart
the host immune response. The reader is referred to several recent
reviews discussing the challenges facing the development of an
anti-biofilm vaccine based on the multi-factorial nature of the
obstacles involved from both the biofilm and immune perspec-
tives (Visai et al., 2007; Harro et al., 2010; Ohlsen and Lorenz,
2010; Montanaro et al., 2011).
POINTS FOR FUTURE CONSIDERATIONS
When considering the host immune response to staphylococcal
biofilms, one must take into account several factors. Particularly,
the method of biofilm propagation in vitro (i.e., static versus shear
flow), in vivomodel, type of immune cell population being exam-
ined, genetic backgroundwhen utilizingmousemodels, pathogen
niche within the host, variability between various staphylococcal
isolates, and the type of biofilm formed (protein vs. polysac-
charide) can all conceivably influence experimental outcomes.
In terms of in vitro biofilm propagation, the compatibility of
medium formulations to achieve optimal survival of both the
biofilm and immune cells must be considered. Although typical
bacterial broth formulations induce robust biofilm growth, they
are likely to induce immune cell apoptosis as we have observed
(Figure 5). Although biofilm maturation was slightly delayed in
mammalian cell culture medium compared to equivalent growth
periods in TSB, biofilms still achieved a relatively uniform thick-
ness and density, along with the presence of tower structures
(Thurlow et al., 2011). In addition, it might be argued that this
medium formulary may better model the host environment that
the bacteria must colonize to establish a biofilm.
Intercellular adhesive mechanisms play a key role in biofilm
development, particularly for S. epidermidis biofilms (Heilmann
et al., 1996; Cramton et al., 1999; Rohde et al., 2007). PIA was
among the first factors identified for mediating biofilm accumula-
tion in S. epidermidis and was later described in S. aureus (Rohde
et al., 2007). Recently the surfactant-like PSM peptides have been
identified as contributors to S. epidermidis and S. aureus biofilm
formation and maturation (Wang et al., 2011; Periasamy et al.,
2012). Proteins have also been found to play an important role
in staphylococcal biofilm formation and in S. epidermidis. Aap
was identified as a PIA-independent intercellular adhesin (Rohde
et al., 2005; Sun et al., 2005). Likewise, PIA-independent S. aureus
FIGURE 5 | TSB medium does not support macrophage survival.
(A) Primary thioglycollate-elicited peritoneal macrophages isolated from
C57BL/6 mice were stained with 5μM CellTracker Orange (orange) and
incubated in RPMI 1640 supplemented with 10% FBS for 24 h at 37◦C.
(B) Primary macrophages isolated from GFP transgenic mice were
incubated in TSB supplemented with 0.5% glucose and 3% NaCl for 24 h at
37◦C. Arrows indicate apoptotic macrophages.
biofilms can also form in humans (Fitzpatrick et al., 2005b;
Toledo-Arana et al., 2005).
While there is an abundance of information on staphylococ-
cal biofilm mutants in vitro (Mann et al., 2009; Beenken et al.,
2010; Kiedrowski et al., 2011) there is limited number of stud-
ies characterizing their impact on host immune mechanisms
in vivo. Moreover, those studies that do investigate the ability
of staphylococcal mutants to establish biofilms in vivo often use
outbred or severely immune compromised mouse strains, which
may have a significant impact on the results obtained. Indeed,
the mouse strain used can greatly influence the experimental
outcome and should be thoughtfully considered when designing
in vivo experiments. Additional studies are needed to further our
understanding of immunity during staphylococcal biofilm infec-
tions in multiple clinically relevant models to identify pathways
that may be exploited for therapy.
CONCLUSIONS
Since staphylococcal biofilms represent a serious clinical situation
based on the propensity of organisms to detach and colonize new
sites of infection (Lowy, 1998; Fätkenheuer et al., 2002), under-
standing host immune-biofilm dynamics is an important issue
that warrants further investigation. Although there is a now a
good foundation documenting immune responses to staphylo-
coccal biofilms, much work remains to be done. In particular,
relatively little is known regarding mechanisms of neutrophil and
macrophage recognition and activation of staphylococcal biofilms
and pathways contributing to fibrotic encapsulation of these
infections. These issues are of particular importance andmay help
explain the phenomenon as to why staphylococcal biofilms are
recalcitrant to therapy and could conceivably unveil candidate
molecules for targeted therapy to augment host immunity to
biofilm infections.
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